Connect Biopharma Holdings (CNTB) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to -$54.8 million.
- Connect Biopharma Holdings' Enterprise Value changed N/A to -$54.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$54.8 million, marking a year-over-year change of. This contributed to the annual value of -$93.7 million for FY2024, which is 2076.95% up from last year.
- According to the latest figures from Q3 2025, Connect Biopharma Holdings' Enterprise Value is -$54.8 million.
- Connect Biopharma Holdings' Enterprise Value's 5-year high stood at -$54.8 million during Q3 2025, with a 5-year trough of -$118.3 million in Q4 2023.
- Moreover, its 3-year median value for Enterprise Value was -$84.0 million (2025), whereas its average is -$87.8 million.
- As far as peak fluctuations go, Connect Biopharma Holdings' Enterprise Value plummeted by 3500.23% in 2024, and later surged by 3485.94% in 2025.
- Over the past 3 years, Connect Biopharma Holdings' Enterprise Value (Quarter) stood at -$118.3 million in 2023, then grew by 20.77% to -$93.7 million in 2024, then surged by 41.56% to -$54.8 million in 2025.
- Its last three reported values are -$54.8 million in Q3 2025, -$71.8 million for Q2 2025, and -$84.0 million during Q1 2025.